Literature DB >> 15539019

[Clinical effect of escin on patients with cutaneous pruritus caused by blood stasis and wind-dryness].

Fu-Lun Li1, Rong Xu, Rong Zhou, Bin Fan, Min Zhou, Wen-Bin Xu, Di-Qing Gu, Ming Zhang, Bin Li.   

Abstract

OBJECTIVE: To observe the clinical effect of escin on patients with cutaneous pruritus caused by blood stasis and wind-dryness and to prove the theory that "wind should be treated by regulating blood disorder, and wind disappears after activating blood" in traditional Chinese medicine (TCM).
METHODS: Fifty-one patients were randomly divided into escin-treated group (n=30) and loratadine-treated group (n=21). The patients in the escin-treated group were treated with escin for 4 weeks (300 mg, b.i.d.), and the patients in the loratadine-treated group were treated with loratadine (10 mg, q.d.). Symptom score reducing index (SSRI) was used to assess the pruritus degree, lesion range and lesion shape before the treatment, 2 weeks and 4 weeks after the treatment, respectively.
RESULTS: Two weeks after the treatment, the effective rate of the escin-treated group was 63.3%, and the effective rate of the loratadine-treated group was 67.0%. Four weeks after the treatment, the effective rates were 86.7% and 80.0% in escin- and loratadine-treated groups respectively. There was no statistical difference in total scores of SSRI in two groups (P>0.05), and the scores of pruritus degree and lesion shape also had no statistical difference (P>0.05), while the score of lesion range of the escin-treated group was lower than that of the loratadine-treated group (P<0.05).
CONCLUSION: Escin has satisfactory effect in treating pruritus caused by blood stasis and wind-dryness. The study confirms the TCM theory that "wind should be treated by regulating blood disorder, and wind disappears after activating blood".

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15539019     DOI: 10.3736/jcim20040607

Source DB:  PubMed          Journal:  Zhong Xi Yi Jie He Xue Bao        ISSN: 1672-1977


  2 in total

1.  Escin, a pentacyclic triterpene, chemosensitizes human tumor cells through inhibition of nuclear factor-kappaB signaling pathway.

Authors:  Kuzhuvelil B Harikumar; Bokyung Sung; Manoj K Pandey; Sushovan Guha; Sunil Krishnan; Bharat B Aggarwal
Journal:  Mol Pharmacol       Date:  2010-01-26       Impact factor: 4.436

2.  Escin Chemosensitizes Human Pancreatic Cancer Cells and Inhibits the Nuclear Factor-kappaB Signaling Pathway.

Authors:  A Rimmon; A Vexler; L Berkovich; G Earon; I Ron; S Lev-Ari
Journal:  Biochem Res Int       Date:  2013-10-27
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.